202 related articles for article (PubMed ID: 18041382)
1. Frequency of anticardiolipin, antinuclear and anti-beta2 glycoprotein I antibodies in children with epilepsy.
Markić J; Mestrović M; Valić I; Sapunar A; Bosnjak N
Coll Antropol; 2007 Sep; 31(3):739-42. PubMed ID: 18041382
[TBL] [Abstract][Full Text] [Related]
2. Anticardiolipin and antinuclear antibodies in epilepsy--a population-based cross-sectional study.
Ranua J; Luoma K; Peltola J; Haapala AM; Raitanen J; Auvinen A; Isojärvi J
Epilepsy Res; 2004 Jan; 58(1):13-8. PubMed ID: 15066670
[TBL] [Abstract][Full Text] [Related]
3. Anti-beta2-glycoprotein I in childhood immune thrombocytopenic purpura.
El-Bostany EA; El-Ghoroury EA; El-Ghafar EA
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):26-31. PubMed ID: 18180612
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to the atheroma component beta2-glycoprotein I and risk of symptomatic peripheral artery disease.
Franck M; Staub HL; Petracco JB; Norman GL; Lassen AJ; Schiavo N; Borges RB; von Mühlen CA
Angiology; 2007; 58(3):295-302. PubMed ID: 17626983
[TBL] [Abstract][Full Text] [Related]
5. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y
Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
[TBL] [Abstract][Full Text] [Related]
6. Anticardiolipin, glutamic acid decarboxylase, and antinuclear antibodies in epileptic patients.
Verrotti A; Greco R; Altobelli E; Latini G; Morgese G; Chiarelli F
Clin Exp Med; 2003 May; 3(1):32-6. PubMed ID: 12748877
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of antiphospholipid and antinuclear antibodies in children with epilepsy.
Constantin T; Kálovics T; Ponyi A; Nagy E; Sallai K; Szabó L; Garami M; Müller J; Gergely P; Dankó K; Fekete G; Kálmánchey R
Med Sci Monit; 2009 Apr; 15(4):CR164-9. PubMed ID: 19333200
[TBL] [Abstract][Full Text] [Related]
8. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease.
Hasegawa EM; Caleiro MT; Fuller R; Carvalho JF
Lupus; 2009 Jun; 18(7):618-21. PubMed ID: 19433462
[TBL] [Abstract][Full Text] [Related]
9. Study of anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with ischemic stroke.
Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M
Rom J Intern Med; 2003; 41(2):189-204. PubMed ID: 15526503
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders.
Peltola JT; Haapala A; Isojärvi JI; Auvinen A; Palmio J; Latvala K; Kulmala P; Laine S; Vaarala O; Keränen T
Am J Med; 2000 Dec; 109(9):712-7. PubMed ID: 11137486
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical significance of anticardiolipin, anti-beta2-glycoprotein-1, and anti-heat shock protein-70 autoantibodies in sudden sensorineural hearing loss.
Gross M; Eliashar R; Ben-Yaakov A; Ulmansky R; Elidan J
Audiol Neurootol; 2008; 13(4):231-8. PubMed ID: 18259075
[TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin and anti-beta2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus.
Tarkun I; Hacihanefioğlu A; Tarkun P; Cetinarslan B; Cantürk Z
Diabetes Res Clin Pract; 2005 Jun; 68(3):181-7. PubMed ID: 15936458
[TBL] [Abstract][Full Text] [Related]
13. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
Marie I; Jouen F; Hellot MF; Levesque H
Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
[TBL] [Abstract][Full Text] [Related]
15. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma.
Bairey O; Blickstein D; Monselise Y; Lahav J; Stark P; Prokocimer M; Nativ HM; Kirgner I; Pazgal I; Shaklai M
Eur J Haematol; 2006 May; 76(5):384-91. PubMed ID: 16466368
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of antinuclear antibodies, anti-neutrophil cytoplasmic antibodies and anticardiolipin antibodies in heroin abusers.
Nikolova M; Liubomirova M; Iliev A; Krasteva R; Andreev E; Radenkova J; Minkova V; Djerassi R; Kiperova B; Vlahov ID
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):908-10. PubMed ID: 12455177
[TBL] [Abstract][Full Text] [Related]
18. Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome.
Ali HY; Abdullah ZA
J Immunotoxicol; 2008 Apr; 5(2):173-7. PubMed ID: 18569388
[TBL] [Abstract][Full Text] [Related]
19. Frequency of anticardiolipin, antinuclear and anti beta2GP1 antibodies is not increased in unselected epileptic patients: a case-control study.
Debourdeau P; Gérome P; Zammit C; Saillol A; Aletti M; Bargues L; Cointet F
Seizure; 2004 Jun; 13(4):205-7. PubMed ID: 15121126
[TBL] [Abstract][Full Text] [Related]
20. Anticardiolipin and antinuclear antibodies in the adult healthy Omani individuals.
Al Jabri AA; Al Buloshi MS
Saudi Med J; 2004 Mar; 25(3):313-7. PubMed ID: 15048168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
